[HTML][HTML] Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 update
JC Nickel, L Aaron, J Barkin, D Elterman… - Canadian Urological …, 2018 - ncbi.nlm.nih.gov
The current document summarizes the state-of-the-art knowledge as it relates to management
of male lower urinary tract symptoms (MLUTS) secondary to benign prostatic hyperplasia (…
of male lower urinary tract symptoms (MLUTS) secondary to benign prostatic hyperplasia (…
WATER II (80–150 mL) procedural outcomes
…, E Kramolowsky, L Doumanian, D Elterman… - BJU …, 2019 - Wiley Online Library
Objectives To present early safety and feasibility data from a multicentre prospective study (WATER
II) of aquablation in the treatment of symptomatic men with large‐volume benign …
II) of aquablation in the treatment of symptomatic men with large‐volume benign …
Aquablation for benign prostatic hyperplasia in large prostates (80–150 mL): 6‐month results from the WATER II trial
…, E Kramolowsky, L Doumanian, D Elterman… - BJU …, 2019 - Wiley Online Library
Objective To present 6‐month safety and effectiveness data from a multicentre prospective
study of aquablation in men with lower urinary tract symptoms (LUTS) attributable to benign …
study of aquablation in men with lower urinary tract symptoms (LUTS) attributable to benign …
Operative time comparison of aquablation, greenlight PVP, ThuLEP, GreenLEP, and HoLEP
…, T Bach, N Bhojani, JE Lingeman, DS Elterman… - World Journal of …, 2020 - Springer
Introduction The BPH surgical armamentarium is composed of a rapidly expanding number
of technologies and techniques. These include greenlight photovaporization of the prostate (…
of technologies and techniques. These include greenlight photovaporization of the prostate (…
Psychological health of surgeons in a time of COVID-19: a global survey
Objective: To assess the degree of psychological impact among surgical providers during
the COVID-19 pandemic. Summary of Background Data: The COVID-19 pandemic has …
the COVID-19 pandemic. Summary of Background Data: The COVID-19 pandemic has …
The quality of life and economic burden of erectile dysfunction
DS Elterman, SK Bhattacharyya, M Mafilios… - … and Reports in …, 2021 - Taylor & Francis
Erectile dysfunction (ED) is a common disorder in adult males that results in withdrawal from
sexual intimacy, psychosocial problems (ie, poor self-esteem, depression, anxiety), …
sexual intimacy, psychosocial problems (ie, poor self-esteem, depression, anxiety), …
Enterococcal urinary tract infections: A review of the pathogenicity, epidemiology, and treatment
A Codelia-Anjum, LB Lerner, D Elterman, KC Zorn… - Antibiotics, 2023 - mdpi.com
Urinary tract infections (UTIs) are among the most common causes of infections worldwide
and can be caused by numerous uropathogens. Enterococci are Gram-positive, facultative …
and can be caused by numerous uropathogens. Enterococci are Gram-positive, facultative …
[PDF][PDF] Medical therapy for benign prostatic hyperplasia: a review
B Van Asseldonk, J Barkin, DS Elterman - Can J Urol, 2015 - canjurol.com
Introduction: Benign prostatic hyperplasia (BPH) is a common disease that affects men as
they age. Historically the treatment has been primarily surgical in nature, but over the past 25 …
they age. Historically the treatment has been primarily surgical in nature, but over the past 25 …
New technologies and applications in sacral neuromodulation: an update
S De Wachter, CH Knowles, DS Elterman… - Advances in …, 2020 - Springer
Recently rechargeable devices have been introduced for sacral neuromodulation (SNM)
with conditional safety for full-body magnetic resonance imaging (MRI). Currently a recharge-…
with conditional safety for full-body magnetic resonance imaging (MRI). Currently a recharge-…
The iTind temporarily implanted nitinol device for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a multicenter, randomized …
B Chughtai, D Elterman, N Shore, M Gittleman… - Urology, 2021 - Elsevier
Objective To report the results of a multicenter, randomized, controlled trial with a temporarily
implanted nitinol device (iTind; Medi-Tate Ltd, Hadera, Israel) compared to sham for the …
implanted nitinol device (iTind; Medi-Tate Ltd, Hadera, Israel) compared to sham for the …